Abbott to Acquire Alere for $5.8 Billion
With the acquisition, Abbott gains leadership in the $5.5 billion point-of-care segment, broadens its diagnostics footprint, and enhances access to fast-growing diagnostics channels.
Read More
Search Results for: point-of-care testing
February 2016 Product Spotlight: Equipment, Consumables, and Labware
This month’s Product Spotlight features equipment, consumables, and labware from companies such as EKF Diagnostics, Olympus, Platinum Code, and Randox Laboratories.
Read MoreTroponin I Assay, Analyzer Designed for Quick Diagnoses at Point of Care
The assay delivers cardiac troponin I results in about 15 minutes from either whole blood or plasma samples.
Read MoreEKF to Sell Back Subsidiary
EKF has agreed to sell its Selah Genomics subsidiary back to cofounders Michael Bolick and Jeremy Stuart for a “nominal” amount.
Read MoreChembio to Commercialize Family of Malaria Assays
The company announced plans to commercialize multiple combination DPP malaria assays to identify Plasmodium falciparum and other Plasmodium infections.
Read More